CDEK by Data4ThePeople
Sign in Sign up
← All organizations

AmpliPhi Biosciences Corporation

For profitWebsite ↗

Also known as: AmpliPhi Biosciences Corporation | Targeted Genetics Corporation

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Jun 1, 2003

Last known activity

May 1, 2016

Acquired by C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics on May 12, 2019

Timeline

1980s

  1. Jun 1, 1989

    AmpliPhi Biosciences Corporation— Founded

2010s

  1. May 1, 2019

    C3J Therapeutics— Acquired

  2. May 12, 2019

    C3J Therapeutics— Acquired By

  3. May 12, 2019

    C3J Therapeutics— Now

Drugs by trial phase (7 distinct, 16 trials)

Phase 3 (0 own, 1 via acquisition)

Phase 2 (0 own, 4 via acquisition)

Phase 1 (0 own, 1 via acquisition)

Other trials (0 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 25 total across the full acquisition tree)

Recent trials (11)

Details

Founded
Richmond, VA, US Jun 1, 1989
Last known activity
May 1, 2016